Home
Market Capitalization of Morepen Laboratories Ltd

Morepen Laboratories Ltd
NSE: MOREPENLAB
Market Cap
Key Highlights
- The Market Cap of Morepen Laboratories Ltd is ₹ 2601 crore as of 26 Mar 25 .
- The Latest Trading Price of Morepen Laboratories Ltd is ₹ 47.47 as of 26 Mar 15:30 .

Morepen Laboratories Ltd
NSE: MOREPENLAB
Share Price
Market Price of Morepen Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
26 Mar 2025 | 47.47 |
25 Mar 2025 | 49.62 |
24 Mar 2025 | 51.72 |
21 Mar 2025 | 50.21 |
20 Mar 2025 | 48.69 |
19 Mar 2025 | 49.42 |
18 Mar 2025 | 48.11 |
17 Mar 2025 | 42.8 |
13 Mar 2025 | 44.66 |
12 Mar 2025 | 44.81 |
SWOT Analysis Of Morepen Laboratories Ltd
BlinkX Score for Morepen Laboratories Ltd
Asset Value vs Market Value of Morepen Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Morepen Laboratories Ltd
Historical P/E Ratio of Morepen Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Morepen Laboratories Ltd
Historical Revenue of Morepen Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Morepen Laboratories Ltd
Historical EBITDA of Morepen Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Morepen Laboratories Ltd
Historical Net Profit of Morepen Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Morepen Laboratories Ltd
Dividend Payout Over Time
About Morepen Laboratories Ltd
- Morepen Laboratories Limited is an India-based pharmaceutical company.
- Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin.
- The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast.
- It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L. The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India.
- The main plant at Parwanoo is inspected and approved by United States Food and Drug Administration (USFDA) for production of Loratadine, which is the best selling anti-allergy drug globally.
Morepen Laboratories Ltd News Hub
Morepen Labs soars after stellar Q1 performance
Net revenue increased by 14% year-over-year (YoY) to Rs 458.64 crore during the period under review.
Read more
12 Aug 24
Morepen Laboratories consolidated net profit rises 147.23% in the June 2024 quarter
Net profit of Morepen Laboratories rose 147.23% to Rs 36.17 crore in the quarter ended June 2024 as
Read more
12 Aug 24
Morepen Laboratories to announce Quarterly Result
Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2024.
Read more
10 Aug 24
Morepen Laboratories successfully concludes QIP issue of Rs 200 cr
Morepen Laboratories announced the successful subscription of a Qualified Institutional Placement (Q
Read more
06 Aug 24